| Literature DB >> 31683845 |
Jorge Cordero1,2, Carlos Alonso-Calleja3,4, Camino García-Fernández5,6, Rosa Capita7,8.
Abstract
An expansion in the consumption of pigeon meat has occurred in recent years. However, little is known about microbial load and antibiotic resistance of this foodstuff. The hygiene status and the antibiotic resistance patterns (disc diffusion; Clinical and Laboratory Standards Institute, CLSI) of Escherichia coli and Enterococcus faecalis isolates from wild and domestic pigeon carcasses were investigated. Average microbial loads (log10 cfu/cm2) ranged from 1.40 ± 1.17 (fecal coliforms) to 3.68 ± 1.40 (psychrotrophs). The highest (p < 0.05) microbial loads were observed in domestic pigeons. No substantial differences were found between isolates from domestic and wild pigeons with regard to the prevalence of antibiotic resistance. Of the E. coli strains, 20.00% were susceptible, 25.00% showed resistance or reduced susceptibility to one antimicrobial and 55.00% were multi-resistant. Among the E. faecalis isolates, 2.22% were susceptible and 97.78% were multi-resistant. The greatest prevalence of resistance or reduced susceptibility among E. coli was observed for amoxicillin-clavulanic acid (20.00% strains), ampicillin (26.67%), streptomycin (55.00%) and tobramycin (20.00%). The prevalence of resistance or reduced susceptibility among E. faecalis ranged from 31.11% (trimethoprim/sulfamethoxazole) to 97.78% (erythromycin). Meat from pigeons is a major reservoir of antibiotic-resistant bacteria. The need for the correct handling of this foodstuff in order to reduce risks to consumers is underlined.Entities:
Keywords: Enterococcus faecalis; Escherichia coli; antibiotic resistance; microbial load; pigeon meat
Year: 2019 PMID: 31683845 PMCID: PMC6915359 DOI: 10.3390/foods8110536
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Culture media, incubation times, temperatures and references used for microbiological analysis.
| Microbial Group | Culture Medium | Incubation | Reference | |
|---|---|---|---|---|
| T (°C) | Time | |||
| Aerobic plate count (APC) 1 | Plate count agar (PCA) | 30 | 72 h | [ |
| Psychrotrophs 1 | Plate count agar (PCA) | 7 | 10 d | [ |
|
| Violet red bile glucose agar (VRBGA) | 35 | 24 h | [ |
| Fecal coliforms 2,3 | Violet red bile agar (VRBA) | 44 | 24 h | [ |
| Enterococci 2 | Kanamycin aesculin azide (KEA) agar | 42 | 24 h | [ |
|
| Mannitol salt agar (MSA) | 35 | 24–48 h | [ |
| Lactic acid bacteria 2 | De Man, Rogosa and Sharpe (MRS) agar | 30 | 72 h | [ |
|
| Streptomycin thallous acetate actidione (STAA) agar | 25 | 48 h | [ |
1 Spread plate technique (0.1 mL); 2 pour plate technique (1 mL); 3 overlay procedure. All media were purchased from Oxoid Ltd. (Hampshire, UK).
Microbial counts (log10 cfu/cm2) on meat from domestic and wild pigeons in Spain.
| Type of Pigeon | |||
|---|---|---|---|
| Microbial Group | Total | Domestic | Wild |
| Aerobic plate count (APC) | 3.16 ± 0.95 c | 3.76 ± 0.92 bb | 2.90 ± 0.84 acd |
| Psychrotrophs | 3.68 ± 1.40 d | 3.84 ± 2.04 ab | 3.61 ± 1.04 ae |
|
| 1.56 ± 1.25 a | 2.06 ± 1.19 ba | 1.35 ± 1.23 aab |
| Fecal coliforms | 1.40 ± 1.17 a | 2.11 ± 1.02 ba | 1.10 ± 1.11 aa |
| Enterococci | 1.82 ± 1.12 a | 2.17 ± 0.85 aa | 1.67 ± 1.20 ab |
|
| 2.73 ± 1.16 b | 3.12 ± 1.05 bb | 2.56 ± 1.17 ac |
| Lactic acid bacteria (LAB) | 3.40 ± 1.04 cd | 3.81 ± 0.93 bb | 3.23 ± 1.05 ade |
|
| 1.53 ± 2.08 a | 1.47 ± 2.17 aa | 1.56 ± 2.05 aab |
Data (average ± STD) in the same row (superscripts) with no letters in common are significantly different (p < 0.05). Data in the same column (subscripts) with no letters in common are significantly different (p < 0.05).
Number and percentage of Escherichia coli strains susceptible, intermediate or resistant to each antibiotic tested.
| Antibiotic | Strains from Domestic Pigeons | Strains from Wild Pigeons ( | All Strains ( | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Isolates | % of Resistant Strains | % of Resistant and Intermediate Strains | Number of Isolates | % of Resistant Strains | % of Resistant and Intermediate Strains | Number of Isolates | % of Resistant Strains | % of Resistant and Intermediate Strains | |||||||
| S | I | R | S | I | R | S | I | R | |||||||
| AMC | 28 | 4 | 0 | 0.00% | 12.50% | 20 | 6 | 2 | 7.14% | 28.57% | 48 | 10 | 2 | 3.33 | 20.00% |
| AMP | 25 | 7 | 0 | 0.00% | 21.88% | 19 | 5 | 4 | 14.29% | 32.14% | 44 | 12 | 4 | 6.67 | 26.67% |
| CAZ | 31 | 1 | 0 | 0.00% | 3.13% | 26 | 2 | 0 | 0.00% | 7.14% | 57 | 3 | 0 | 0.00 | 5.00% |
| CTX | 27 | 4 | 1 | 3.13% | 15.63% | 25 | 3 | 0 | 0.00% | 10.71% | 52 | 7 | 1 | 1.67 | 13.33% |
| FOX | 32 | 0 | 0 | 0.00% | 0.00% | 24 | 1 | 3 | 10.71% | 14.29% | 56 | 1 | 3 | 5.00 | 6.67% |
| IPM | 32 | 0 | 0 | 0.00% | 0.00% | 28 | 0 | 0 | 0.00% | 0.00% | 60 | 0 | 0 | 0.00 | 0.00% |
| ATM | 28 | 3 | 1 | 3.13% | 12.50% | 23 | 1 | 4 | 14.29% | 17.86% | 51 | 4 | 5 | 8.33 | 15.00% |
| NA | 32 | 0 | 0 | 0.00% | 0.00% | 25 | 2 | 1 | 3.57% | 10.71% | 57 | 2 | 1 | 1.67 | 5.00% |
| CIP | 32 | 0 | 0 | 0.00% | 0.00% | 27 | 1 | 0 | 0.00% | 3.57% | 59 | 1 | 0 | 0.00 | 1.67% |
| C | 30 | 2 | 0 | 0.00% | 6.25% | 27 | 1 | 0 | 0.00% | 3.57% | 57 | 3 | 0 | 0.00 | 5.00% |
| CN | 30 | 2 | 0 | 0.00% | 6.25% | 23 | 0 | 5 | 17.86% | 17.86% | 53 | 2 | 5 | 8.33 | 11.67% |
| AK | 31 | 1 | 0 | 0.00% | 3.13% | 22 | 2 | 4 | 14.29% | 21.43% | 53 | 3 | 4 | 6.67 | 11.67% |
| STR | 15 | 15 | 2 | 6.25% | 53.13% | 12 | 15 | 1 | 3.57% | 57.14% | 27 | 30 | 3 | 5.00 | 55.00% |
| TOB | 27 | 4 | 1 | 3.13% | 15.63% | 21 | 4 | 3 | 10.71% | 25.00% | 48 | 8 | 4 | 6.67 | 20.00% |
| TE | 31 | 0 | 1 | 3.13% | 3.13% | 25 | 2 | 1 | 3.57% | 10.71% | 56 | 2 | 2 | 3.33 | 6.67% |
| SXT | 32 | 0 | 0 | 0.00% | 0.00% | 28 | 0 | 0 | 0.00% | 0.00% | 60 | 0 | 0 | 0.00 | 0.00% |
Amoxicillin-clavulanic acid (AMC); ampicillin (AMP); ceftazidime (CAZ); cefotaxime (CTX); cefoxitin (FOX); imipenem (IPM); aztreonam (ATM); nalidixic acid (NA); ciprofloxacin (CIP); chloramphenicol (C); gentamicin (CN); amikacin (AK); streptomycin (STR); tobramycin (TOB); tetracycline (TE); trimethoprim-sulfamethoxazole (SXT).
Figure 1Percentage of Escherichia coli strains susceptible, intermediate or resistant to each antibiotic tested. Amoxicillin-clavulanic acid (AMC); ampicillin (AMP); ceftazidime (CAZ); cefotaxime (CTX); cefoxitin (FOX); imipenem (IPM); aztreonam (ATM); nalidixic acid (NA); ciprofloxacin (CIP); chloramphenicol (C); gentamicin (CN); amikacin (AK); streptomycin (STR); tobramycin (TOB); tetracycline (TE); trimethoprim-sulfamethoxazole (SXT).
Figure 2Percentage of Escherichia coli strains from domestic and wild pigeons with resistance or reduced susceptibility to each antibiotic tested. Amoxicillin-clavulanic acid (AMC); ampicillin (AMP); ceftazidime (CAZ); cefotaxime (CTX); cefoxitin (FOX); imipenem (IPM); aztreonam (ATM); nalidixic acid (NA); ciprofloxacin (CIP); chloramphenicol (C); gentamicin (CN); amikacin (AK); streptomycin (STR); tobramycin (TOB); tetracycline (TE); trimethoprim-sulfamethoxazole (SXT).
Number and percentage of Enterococcus faecalis strains susceptible, intermediate or resistant to each antibiotic tested.
| Antibiotic | Strains from Domestic Pigeons ( | Strains from Wild Pigeons ( | All Strains ( | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Isolates | % of Resistant Strains | % of Resistant and Intermediate Strains | Number of Isolates | % of Resistant Strains | % of Resistant and Intermediate Strains | Number of Isolates | % of Resistant Strains | % of Resistant and Intermediate Strains | |||||||
| S | I | R | S | I | R | S | I | R | |||||||
| AMP | 4 | 10 | 2 | 12,50% | 75.00% | 13 | 8 | 8 | 27.59% | 55.17% | 17 | 18 | 10 | 22.22% | 62.22% |
| CIP | 0 | 4 | 12 | 75.00% | 100% | 3 | 13 | 13 | 44.83% | 89.66% | 3 | 17 | 25 | 55.56% | 93.33% |
| C | 7 | 9 | 0 | 0.00% | 56.25% | 3 | 25 | 1 | 3.45% | 89.66% | 10 | 34 | 1 | 2.22% | 77.78% |
| CN | 3 | 6 | 7 | 43.75% | 81.25% | 3 | 3 | 23 | 79.31% | 89.66% | 6 | 9 | 30 | 66.67% | 86.67% |
| K | 0 | 2 | 14 | 87.50% | 100% | 7 | 4 | 18 | 62.07% | 75.86% | 7 | 6 | 32 | 71.11% | 84.44% |
| STR | 0 | 1 | 15 | 93.75% | 100% | 3 | 1 | 25 | 86.21% | 89.66% | 3 | 2 | 40 | 88.89% | 93.33% |
| E | 0 | 9 | 7 | 43.75% | 100% | 1 | 19 | 9 | 31.03% | 96.55% | 1 | 28 | 16 | 35.56% | 97.78% |
| FOS | 7 | 6 | 3 | 18.75% | 56.25% | 14 | 11 | 4 | 13.79% | 51.72% | 21 | 17 | 7 | 15.56% | 53.33% |
| F | 3 | 5 | 8 | 50.00% | 81.25% | 4 | 5 | 20 | 68.97% | 86.21% | 7 | 10 | 28 | 62.22% | 84.44% |
| RD | 7 | 3 | 6 | 37.50% | 56.25% | 3 | 6 | 20 | 68.97% | 89.66% | 10 | 9 | 26 | 57.78% | 77.78% |
| TEC | 7 | 9 | 0 | 0.00% | 56.25% | 22 | 6 | 1 | 3.45% | 24.14% | 29 | 15 | 1 | 2.22% | 35.56% |
| VA | 6 | 9 | 1 | 6.25% | 62.50% | 5 | 19 | 5 | 17.24% | 82.76% | 11 | 28 | 6 | 13.33% | 75.56% |
| TE | 0 | 5 | 11 | 68.75% | 100% | 2 | 10 | 17 | 58.62% | 93.10% | 2 | 15 | 28 | 62.22% | 95.56% |
| SXT | 11 | 5 | 0 | 0.00% | 31.25% | 20 | 8 | 1 | 3.45% | 31.03% | 31 | 13 | 1 | 2.22% | 31.11% |
Ampicillin (AMP); ciprofloxacin (CIP); chloramphenicol (C); gentamicin (CN); kanamycin (K); streptomycin (STR); erythromycin (E); fosfomycin (FOS); nitrofurantoin (F); rifampicin (RD); teicoplanin (TEC); vancomycin (VA), tetracycline (TE); trimethoprim-sulfamethoxazole (SXT).
Figure 3Percentage of Enterococcus faecalis strains susceptible, intermediate or resistant to each antibiotic tested. Ampicillin (AMP); ciprofloxacin (CIP); chloramphenicol (C); gentamicin (CN); kanamycin (K); streptomycin (STR); erythromycin (E); fosfomycin (FOS); nitrofurantoin (F); rifampicin (RD); teicoplanin (TEC); vancomycin (VA), tetracycline (TE); trimethoprim-sulfamethoxazole (SXT).
Figure 4Percentage of Enterococcus faecalis strains from domestic and wild pigeons with resistance or reduced susceptibility to each antibiotic tested. Ampicillin (AMP); ciprofloxacin (CIP); chloramphenicol (C); gentamicin (CN); kanamycin (K); streptomycin (STR); erythromycin (E); fosfomycin (FOS); nitrofurantoin (F); rifampicin (RD); teicoplanin (TEC); vancomycin (VA), tetracycline (TE); trimethoprim-sulfamethoxazole (SXT).